IMMUCELL CORP /DE/ (ICCC) reporting calendar
IMMUCELL CORP /DE/ files periodic reports with the SEC as ICCC on Nasdaq. Atlas tracks 115 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 22 Jul 2026 – 4 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 14 May 2026
- Reports on record
- 115
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 14 May 2026 | 44 days | 0001437749-26-017045 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001437749-26-010339 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001437749-25-034817 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0001213900-25-076635 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0001213900-25-043287 |
| 10-K | 31 Dec 2024 | 28 Mar 2025 | 87 days | 0001013762-25-004072 |
| 10-Q | 30 Sep 2024 | 13 Nov 2024 | 44 days | 0001213900-24-097450 |
| 10-Q | 30 Jun 2024 | 13 Aug 2024 | 44 days | 0001213900-24-068245 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0001213900-24-042925 |
| 10-K | 31 Dec 2023 | 1 Apr 2024 | 92 days | 0001213900-24-028718 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0001213900-23-086092 |
| 10-Q | 30 Jun 2023 | 10 Aug 2023 | 41 days | 0001213900-23-065595 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0001213900-23-038529 |
| 10-K | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001213900-23-024080 |
| 10-Q | 30 Sep 2022 | 21 Nov 2022 | 52 days | 0001213900-22-074215 |
| 10-Q | 30 Jun 2022 | 11 Aug 2022 | 42 days | 0001213900-22-046861 |
| 10-Q | 31 Mar 2022 | 12 May 2022 | 42 days | 0001213900-22-025936 |
| 10-K | 31 Dec 2021 | 30 Mar 2022 | 89 days | 0001213900-22-016147 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001213900-21-059332 |
| 10-Q | 30 Jun 2021 | 12 Aug 2021 | 43 days | 0001213900-21-042017 |
| 10-Q | 31 Mar 2021 | 13 May 2021 | 43 days | 0001213900-21-026068 |
| 10-K | 31 Dec 2020 | 30 Mar 2021 | 89 days | 0001213900-21-018473 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001213900-20-036536 |
| 10-Q | 30 Jun 2020 | 12 Aug 2020 | 43 days | 0001213900-20-021605 |
| 10-Q | 31 Mar 2020 | 13 May 2020 | 43 days | 0001213900-20-011986 |
| 10-K | 31 Dec 2019 | 27 Mar 2020 | 87 days | 0001213900-20-007650 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001213900-19-022739 |
| 10-Q | 30 Jun 2019 | 12 Aug 2019 | 43 days | 0001213900-19-015331 |
| 10-Q | 31 Mar 2019 | 13 May 2019 | 43 days | 0001213900-19-008423 |
| 10-K | 31 Dec 2018 | 22 Mar 2019 | 81 days | 0001213900-19-004653 |
| 10-Q | 30 Sep 2018 | 13 Nov 2018 | 44 days | 0001213900-18-015491 |
| 10-Q | 30 Jun 2018 | 13 Aug 2018 | 44 days | 0001213900-18-010819 |
| 10-Q | 31 Mar 2018 | 14 May 2018 | 44 days | 0001213900-18-006104 |
| 10-K | 31 Dec 2017 | 29 Mar 2018 | 88 days | 0001213900-18-003621 |
| 10-Q | 30 Sep 2017 | 13 Nov 2017 | 44 days | 0001213900-17-011859 |
| 10-Q | 30 Jun 2017 | 14 Aug 2017 | 45 days | 0001213900-17-008652 |
| 10-Q | 31 Mar 2017 | 11 May 2017 | 41 days | 0001213900-17-004937 |
| 10-K | 31 Dec 2016 | 30 Mar 2017 | 89 days | 0001213900-17-003009 |
| 10-Q | 30 Sep 2016 | 10 Nov 2016 | 41 days | 0001213900-16-018201 |
| 10-Q | 30 Jun 2016 | 11 Aug 2016 | 42 days | 0001213900-16-015764 |
Source: SEC EDGAR company submissions for CIK 0000811641. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.